CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,577 | $12.65 | $33K | 304,606 |
| 2021-04-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −1,999 | $14.47 | $29K | 307,183 |
| 2021-03-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −1,998 | $13.55 | $27K | 309,182 |
| 2021-03-01 | Hodges Philip Director | Sale | −6,000 | $16.08 | $96K | 8,731 |
| 2021-02-28 | Garg Vipin K President and CEO | Shares withheld for taxes | −1,998 | $15.94 | $32K | 311,180 |
| 2021-02-25 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Other disposition | −1,000,000 | 3,500,000 | ||
| 2021-02-25 | Venrock Healthcare Capital Partners III, L.P. 10% owner | Other acquisition · Warrant | +1,000,000 | 1,000,000 | ||
| 2021-02-01 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +90,000 | 90,000 | ||
| 2021-02-01 | Harris Matthew Scott Chief Medical Officer | Grant or award · Restricted Stock Units | +24,664 | 24,664 | ||
| 2021-02-01 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +90,000 | 90,000 | ||
| 2021-02-01 | Roberts M Scot Chief Scientific Officer | Grant or award · Restricted Stock Units | +24,664 | 24,664 | ||
| 2021-02-01 | Brown William Michael Chief Financial Officer | Grant or award · Stock Options (option to buy) | +90,000 | 90,000 | ||
| 2021-02-01 | Brown William Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +24,664 | 24,664 | ||
| 2021-02-01 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +241,500 | 241,500 | ||
| 2021-02-01 | Garg Vipin K President and CEO | Grant or award · Restricted Stock Units | +66,181 | 66,181 | ||
| 2021-01-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +968 | $12.14 | $12K | 5,037 |
| 2021-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +467 | $12.14 | $6K | 9,861 |
| 2021-01-31 | Brown William Michael Chief Financial Officer | Grant or award | +937 | $12.14 | $11K | 16,918 |
| 2021-01-31 | Garg Vipin K President and CEO | Grant or award | +1,055 | $12.14 | $13K | 313,178 |
| 2021-01-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,353 | $14.28 | $34K | 312,123 |
Page 20 of 29 · 568 trades